TerminatedNCT06431386
Behavioural Activation Therapy and Esketamine for Resistant Depression
This study assesses depression symptoms.
Medication studyAges 18–65Canada
Understand this study
What is this study about?
This study assesses depression symptoms.
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- OttawaSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 11, 2024
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 6
- Sponsor
- The Royal's Institute of Mental Health Research
- Sponsor type
- Research institute
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Not clearly listed
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06431386
- Official title
Show the full official title
Optimizing the Synergy Between Behavioural Activation Therapy and Esketamine for Resistant Depression
Recruitment & locations
TerminatedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Ottawa
Interested in joining this study?
Questions about this study
What is this study about?
This study assesses depression symptoms.
Who is behind this study?
The study sponsor is The Royal's Institute of Mental Health Research, a research institute.
Does this study involve medication?
Yes. The study involves medication, including Esketamine.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
